CD90.2 antibody

Ref. 3D-10R-6447

Produktinformation

• Name: CD90.2 antibody

Beschreibung

The CD90.2 antibody is a monoclonal antibody that specifically targets and binds to CD90.2, a cell surface protein also known as Thy1. It has been shown to be effective in blocking the activity of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), two pro-inflammatory cytokines involved in various diseases and immune responses.

This monoclonal antibody is commonly used in Life Sciences research, particularly in studies related to immunology, cancer biology, and regenerative medicine. Its ability to bind to CD90.2 allows researchers to selectively target and study specific cell populations expressing this protein.

In addition to its research applications, the CD90.2 antibody has potential therapeutic uses. By targeting CD90.2-positive cells, it can be used as a medicament for the treatment of certain diseases or conditions characterized by abnormal or overactive cell growth. Its cytotoxic properties make it a promising candidate for targeted therapy against cancer cells expressing

• Marke: Biosynth